Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantation.

Ng FL, Holt DW, MacPhee IA.

Expert Opin Pharmacother. 2007 Sep;8(13):2045-58. Review.

PMID:
17714059
2.

Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?

MacPhee IA, Fredericks S, Holt DW.

Expert Opin Pharmacother. 2005 Dec;6(15):2593-605. Review.

PMID:
16316299
3.

Pharmacogenetics of immunosuppressants: progress, pitfalls and promises.

Cattaneo D, Baldelli S, Perico N.

Am J Transplant. 2008 Jul;8(7):1374-83. doi: 10.1111/j.1600-6143.2008.02263.x. Review.

4.

Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients.

Ekbal NJ, Holt DW, Macphee IA.

Pharmacogenomics. 2008 May;9(5):585-96. doi: 10.2217/14622416.9.5.585. Review.

PMID:
18466104
5.

The pharmacogenetics of immunosuppression for organ transplantation: a route to individualization of drug administration.

Fredericks S, Holt DW, MacPhee IA.

Am J Pharmacogenomics. 2003;3(5):291-301. Review.

PMID:
14575518
6.

Genetic polymorphisms influencing therapy and susceptibility to rejection in organ allograft recipients.

Poli F, Piccolo G, Scalamogna M.

BioDrugs. 2002;16(1):11-7. Review.

PMID:
11908998
7.

Current progress in pharmacogenetics and individualized immunosuppressive drug dosing in organ transplantation.

Ware N, MacPhee IA.

Curr Opin Mol Ther. 2010 Jun;12(3):270-83. Review.

PMID:
20521216
8.

Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs.

Kurzawski M, Droździk M.

Pharmacogenomics. 2013 Jul;14(9):1099-118. doi: 10.2217/pgs.13.89. Review.

PMID:
23837483
9.

Practicability of pharmacogenetics in transplantation medicine.

van Gelder T, van Schaik RH, Hesselink DA.

Clin Pharmacol Ther. 2014 Mar;95(3):262-4. doi: 10.1038/clpt.2013.169. Epub 2013 Aug 29. Review.

PMID:
23995265
10.

Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives.

Anglicheau D, Legendre C, Thervet E.

Transplantation. 2004 Aug 15;78(3):311-5. Review.

PMID:
15316356
11.

Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome.

Mourad M, Wallemacq P, De Meyer M, Malaise J, De Pauw L, Eddour DC, Goffin E, Lerut J, Haufroid V.

Transplantation. 2008 Apr 15;85(7 Suppl):S19-24. doi: 10.1097/TP.0b013e318169c380. Review.

PMID:
18401258
12.

Pharmacogenetic differences and drug-drug interactions in immunosuppressive therapy.

Warrington JS, Shaw LM.

Expert Opin Drug Metab Toxicol. 2005 Oct;1(3):487-503. Review.

PMID:
16863457
13.

[Pharmacogenetics and immunosuppressor drugs: impact and clinical interest in transplantation].

Marquet P, Djebli N, Picard N.

Ann Pharm Fr. 2007 Nov;65(6):382-9. Review. French.

PMID:
18079670
14.

Pharmacogenetics in solid organ transplantation: current status and future directions.

de Jonge H, Kuypers DR.

Transplant Rev (Orlando). 2008 Jan;22(1):6-20. doi: 10.1016/j.trre.2007.09.002. Review.

PMID:
18631854
15.

Genetic factors for individual administration of immunosuppressants in organ transplantation.

Yu SF, Wu LH, Zheng SS.

Hepatobiliary Pancreat Dis Int. 2006 Aug;5(3):337-44.

16.

Pharmacogenomics: the key to improved drug therapy in transplant patients.

Burckart GJ.

Clin Lab Med. 2008 Sep;28(3):411-22, vi. doi: 10.1016/j.cll.2008.09.004. Review.

PMID:
19028260
17.

Basic immunosuppressive drugs outside solid organ transplantation.

Braun F, Behrend M.

Expert Opin Investig Drugs. 2006 Mar;15(3):267-91. Review.

PMID:
16503764
18.

Genetic polymorphisms and the fate of the transplanted organ.

Krüger B, Schröppel B, Murphy BT.

Transplant Rev (Orlando). 2008 Apr;22(2):131-40. doi: 10.1016/j.trre.2007.12.002. Review.

PMID:
18631866
19.

Evolving trends in induction therapy.

Arias M, Campistol JM, Vincenti F.

Transplant Rev (Orlando). 2009 Apr;23(2):94-102. doi: 10.1016/j.trre.2009.01.004. Review.

PMID:
19298940
20.

[Therapeutic failure: importance of genes?].

Lhermitte M, Allorge D, Broly F.

Ann Pharm Fr. 2006 Nov;64(6):406-15. Review. French.

PMID:
17119471

Supplemental Content

Support Center